Key Record Dates
ClinicalTrials.gov Identifier: | NCT04409262 |
---|---|
Brief Title: | A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia (REMDACTA) |
First Submitted : | May 28, 2020 |
First Submitted that Met QC Criteria : | May 28, 2020 |
First Posted : | June 1, 2020 |
Results First Submitted : | January 28, 2022 |
Results First Submitted that Met QC Criteria : | January 28, 2022 |
Results First Posted : | February 14, 2022 |
Last Update Submitted that Met QC Criteria : | January 28, 2022 |
Last Update Posted : | February 14, 2022 |